
Asparawem 5000IU Injection
Salt Composition: L- Asparaginase
Expiry Date: 01/2028
Inclusive of all taxes
1 vial(s)5
About The Product
lymphoblastic leukemia
Description
Asparawem 500IU Injection is an anti-cancer medication. It is used in the treatment of lymphoblastic leukemia by breaking down the amino acid asparagine.
Through which cancerous lymphoblast cannot produce on their own, they stopping their growth. The medication active ingredient is L- Asparaginase, an enzyme that specifically hydrolyzes asparagine into aspartic acid and ammonia, leading to cancer cell growth.
The medication should be taken under strict medical supervision. Avoid taking this medication under the age of 18.
Uses
Lymphoblastic leukemia
Common side effects
- Asparawem 500IU Injection may cause side effects like any other medication have, consult the doctor before taking the medication to ensure safety and effectiveness of the treatment.
- Here are some common side effects: ● Nausea ● Muscle pain ● Weight loss ● Infections (fever, rapid heart rate, confusion, or a rash) ● Difficulty breathing ● Inflammation of the digestive tract ● High blood sugar levels ● Bleeding ● Liver and nervous problems ● Pain near your stomach (inflammation of the pancreas) ● Blood clots in arm or leg
How to use
- Asparawen 500IU injection can be taken with or without food.
- Take the medication with a whole glass of water.
- Do not skip or stop the medicine without consultation from a healthcare provider.
- It should always be administered under medical supervision and dosage or schedule must be followed exactly to avoid complications.
How it works
In acute lymphoblastic leukemia, the white blood cells called lymphocytes multiplied in uncontrolled manner. Asparaginase is an enzyme that interferes with natural processes necessary for cancer cell growth, thereby killing or stopping the cancer cell growth.
Thereby it killing or stopping the growth of tumors in the body. Doctor's use this medication as a primary source of blood cancer.
Safety advice
FAQs
Asparawen 500IU injection is taken by the patient of blood cancer by allowing the enzyme L- Asparaginase to enter the blood stream and deplete asparagine which stops the growth of leukemia cells.
Reference
• Batool, T., Makky, E. A., Jalal, M., & Yusoff, M.
M. (2016).
A comprehensive review on L-asparaginase and its applications. Applied biochemistry and biotechnology, 178(5), 900-927. • Keating, M.
J., Holmes, R., Lerner, S., & Ho, D. H.
(1993). L-asparaginase and PEG asparaginase—past, present, and future.
Leukemia & lymphoma, 10(sup1), 153-157. • Müller, H. J., & Boos, J.
(1998). Use of L-asparaginase in childhood ALL.
Critical reviews in oncology/hematology, 28(2), 97-113. • Verma, N., Kumar, K., Kaur, G., & Anand, S. (2007).
L-asparaginase: a promising chemotherapeutic agent. Critical reviews in biotechnology, 27(1), 45-62. • Whitecar Jr, J.
P., Bodey, G. P., Harris, J.
E., & Freireich, E. J.
(1970). L-asparaginase.
New England Journal of Medicine, 282(13), 732-734.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
